Publications des membres du comité de pilotage de l'étude d'épidémiologie moléculaire des GIST en France

  • Publications originales
  • Recommandations, synthèse
  • Publications en langue française
  • Publications originales

    (2006, 2005, 2004, 2003, 2002, 2001, 2000)
    2006


    Bonvalot S, Eldweny H, Pechoux CL, Vanel D, Terrier P, Cavalcanti A, Robert C, Lassau N, Cesne AL.
    Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era.
    Ann Surg Oncol. 2006 Sep 7; [Epub ahead of print]

    Van Glabbeke M, Verweij J, Casali PG, Simes J, Le Cesne A, Reichardt P, Issels R, Judson IR, van Oosterom AT, Blay JY.
    Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: a study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG).
    Eur J Cancer. 2006 Sep;42(14):2277-85. Epub 2006 Jul 28.

    Bertucci F, Goncalves A, Monges G, Madroszyk A, Guiramand J, Moutardier V, Noguchi T, Dubreuil P, Sobol H.
    Acquired resistance to imatinib and secondary KIT exon 13 mutation in gastrointestinal stromal tumour.
    Oncol Rep. 2006 Jul;16(1):97-101.

    Debiec-Rychter M, Sciot R, Le Cesne A, Schlemmer M, Hohenberger P, van Oosterom AT, Blay JY, Leyvraz S, Stul M, Casali PG, Zalcberg J, Verweij J, Van Glabbeke M, Hagemeijer A, Judson I; EORTC Soft Tissue and Bone Sarcoma Group; The Italian Sarcoma Group; Australasian GastroIntestinal Trials Group
    KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.
    Eur J Cancer. 2006 May;42(8):1093-103. Epub 2006 Apr 18.

    Theou-Anton N, Tabone S, Brouty-Boye D, Saffroy R, Ronnstrand L, Lemoine A, Emile JF.
    Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.
    Br J Cancer. 2006 Apr 24;94(8):1180-5.

    Hostein I, Longy M, Gastaldello B, Geneste G, Coindre JM.
    Detection of a new mutation in KIT exon 9 in a gastrointestinal stromal tumor.
    Int J Cancer. 2006 Apr 15;118(8):2089-91.
    Retour en haut de la page
    2005


    Theou N, Gil S, Devocelle A, Julie C, Lavergne-Slove A, Beauchet A, Callard P, Farinotti R, Le Cesne A, Lemoine A, Faivre-Bonhomme L, Emile JF.
    Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib.
    Clin Cancer Res. 2005 Nov 1;11(21):7593-8.

    Van Glabbeke M, Verweij J, Casali PG, Le Cesne A, Hohenberger P, Ray-Coquard I, Schlemmer M, van Oosterom AT, Goldstein D, Sciot R, Hogendoorn PC, Brown M, Bertulli R, Judson IR.
    Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study.
    J Clin Oncol. 2005 Aug 20;23(24):5795-804.

    Zalcberg JR, Verweij J, Casali PG, Le Cesne A, Reichardt P, Blay JY, Schlemmer M, Van Glabbeke M, Brown M, Judson IR; EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group; Australasian Gastrointestinal Trials Group.
    Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg.
    Eur J Cancer. 2005 Aug;41(12):1751-7.

    Therasse P, Le Cesne A, Van Glabbeke M, Verweij J, Judson I; for the EORTC Soft Tissue and Bone Sarcoma Group.
    RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma.
    Eur J Cancer. 2005 Jul;41(10):1426-30.

    Tabone S, Theou N, Wozniak A, Saffroy R, Deville L, Julie C, Callard P, Lavergne-Slove A, Debiec-Rychter M, Lemoine A, Emile JF.
    KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs).
    Biochim Biophys Acta. 2005 Jun 30;1741(1-2):165-72. Epub 2005 Apr 13.

    Vanel D, Albiter M, Shapeero L, Le Cesne A, Bonvalot S, Le Pechoux C, Terrier P, Petrow P, Caillet H, Dromain C.
    Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients.
    Eur J Radiol. 2005 Apr;54(1):118-23.
    Retour en haut de la page
    2004


    Aparicio T, Boige V, Sabourin JC, Crenn P, Ducreux M, Le Cesne A, Bonvalot S.
    Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.
    Eur J Surg Oncol. 2004 Dec;30(10):1098-103.

    Bompas E, Velay B, Blay JY.
    treatment of rituximab and imatinib mesylate for simultaneous relapse of MALT lymphoma and a gastrointestinal stromal tumor.
    Leuk Lymphoma. 2004 Nov;45(11):2353-4.

    Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PC, Van Glabbeke M, Bertulli R, Judson I.
    Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.
    Lancet. 2004 Sep 25-Oct 1;364(9440):1127-34.

    Borg C, Terme M, Taieb J, Menard C, Flament C, Robert C, Maruyama K, Wakasugi H, Angevin E, Thielemans K, Le Cesne A, Chung-Scott V, Lazar V, Tchou I, Crepineau F, Lemoine F, Bernard J, Fletcher JA, Turhan A, Blay JY, Spatz A, Emile JF, Heinrich MC, Mecheri S, Tursz T, Zitvogel L.
    Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects.
    J Clin Invest. 2004 Aug;114(3):379-88.

    Emile JF, Theou N, Tabone S, Cortez A, Terrier P, Chaumette MT, Julie C, Bertheau P, Lavergne-Slove A, Donadieu J, Barrier A, Le Cesne A, Debuire B, Lemoine A; Groupe d'Etude des GIST.
    Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors.
    Clin Gastroenterol Hepatol. 2004 Jul;2(7):597-605.

    Bompas E, Boillot O, Bringuier PP, Dumortier J, Blay JY.
    Imatinib in patients with metastatic gastrointestinal stromal tumours relapsing after hepatic transplantation.
    Eur J Cancer. 2004 Jun;40(9):1456-7.

    Blay JY, Le Cesne A, Verweij J, Scurr M, Seynaeve C, Bonvalot S, Hogendoorn P, Jimeno J, Evrard V, van Glabbeke M, Judson I.
    A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours.
    Eur J Cancer. 2004 Jun;40(9):1327-31.

    Theou N, Tabone S, Saffroy R, Le Cesne A, Julie C, Cortez A, Lavergne-Slove A, Debuire B, Lemoine A, Emile JF.
    High expression of both mutant and wild-type alleles of c-kit in gastrointestinal stromal tumors.
    Biochim Biophys Acta. 2004 Apr 5;1688(3):250-6.
    Retour en haut de la page
    2003


    Verweij J, van Oosterom A, Blay JY, Judson I, Rodenhuis S, van der Graaf W, Radford J, Le Cesne A, Hogendoorn PC, di Paola ED, Brown M, Nielsen OS. Related Articles, Links
    Abstract Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study.
    Eur J Cancer. 2003 Sep;39(14):2006-11.

    2002

    Emile JF, Lemoine A, Bienfait N, Terrier P, Azoulay D, Debuire B.
    Length analysis of polymerase chain reaction products: a sensitive and reliable technique for the detection of mutations in KIT exon 11 in gastrointestinal stromal tumors.
    Diagn Mol Pathol. 2002 Jun;11(2):107-12.

    2001

    Judson I, Radford JA, Harris M, Blay JY, van Hoesel Q, le Cesne A, van Oosterom AT, Clemons MJ, Kamby C, Hermans C, Whittaker J, Donato di Paola E, Verweij J, Nielsen S.
    Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group.
    Eur J Cancer. 2001 May;37(7):870-7.

    2000

    Palazzo L, Landi B, Cellier C, Cuillerier E, Roseau G, Barbier JP.
    Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours.
    Gut. 2000 Jan;46(1):88-92.
    Retour en haut de la page

    Recommandations, synthèse

    2006
    Blackstein ME, Blay JY, Corless C, Driman DK, Riddell R, Soulieres D, Swallow CJ, Verma S; Canadian Advisory Committee on GIST.
    Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment.
    Can J Gastroenterol. 2006 Mar;20(3):157-63.

    Benjamin RS, Blanke CD, Blay JY, Bonvalot S, Eisenberg B.
    Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
    Oncologist. 2006 Jan;11(1):9-20. Review.

    2005
    Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, Emile JF, Gronchi A, Hogendoorn PC, Joensuu H, Le Cesne A, McClure J, Maurel J, Nupponen N, Ray-Coquard I, Reichardt P, Sciot R, Stroobants S, van Glabbeke M, van Oosterom A, Demetri GD; GIST consensus meeting panelists.
    Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
    Ann Oncol. 2005 Apr;16(4):566-78. Review.

    2003
    Duffaud F, Blay JY. Gastrointestinal stromal tumors: biology and treatment.
    Oncology. 2003;65(3):187-97. Review.
    Retour en haut de la page

    Publications en langue française

    (2006, 2005, 2004, 2003, 2002, 2001)
    2006

    Bouche O, Lagarde S, Guillou PJ, Ramaholimihaso F, Lubrano D, Diebold MD, Delattre JF, Nguyen TD, Cadiot G, Thiefin G.
    [Flushing revealing the recurrence of a rectal gastrointestinal stromal tumour. Efficacy of imatinib]
    Gastroenterol Clin Biol. 2006 Apr;30(4):636-7. French.

    Bonvalot S, Le Cesne A.
    [Diagnosis and treatment of gastrointestinal stromal tumours]
    Rev Prat. 2006 Feb 28;56(4):359-67. Review. French.

    Guillaud O, Dumortier J, Bringuier PP, Saurin JC, Poncet G, Boulez J, Henry L, Chayvialle JA, Scoazec JY.
    [Multiple gastro-intestinal stromal tumors (GIST) in a patient with type I neurofibromatosis revealed by chronic bleeding: pre-operative radiological diagnosis]
    Gastroenterol Clin Biol. 2006 Feb;30(2):320-4. French.

    Collin F, Gelly-Marty M, Bui Nguyen Binh M, Coindre JM.
    [Soft tissue sarcomas: current data in the field of pathology]
    Cancer Radiother. 2006 Feb-Mar;10(1-2):7-14. Epub 2005 Nov 28. Review. French.

    Bui Nguyen Binh M, Collin F, Coindre JM.
    [Soft tissue sarcomas: update on molecular data]
    Cancer Radiother. 2006 Feb-Mar;10(1-2):15-21. Epub 2006 Jan 27. Review. French.
    Retour en haut de la page

    2005

    Lapalus MG, Hervieu V, Crombe-Ternamian A, Scoazec JY, Valette PJ, Stremsdoerfer N, Poncet G.
    [Small bowel stromal tumor: a multitechnique diagnostic approach by video-capsule and CT scan]
    Gastroenterol Clin Biol. 2005 Nov;29(11):1183-5. French.

    Coindre JM, Emile JF, Monges G, Ranchere-Vince D, Scoazec JY.
    [Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy]
    Ann Pathol. 2005 Oct;25(5):358-85; quiz 357. Review. French.

    Blay JY, Landi B, Bonvalot S, Monges G, Ray-Coquard I, Duffaud F, Bui NB, Bugat R, Chayvialle JA, Rougier P, Bouche O, Bonichon F, Lassau N, Vanel D, Nordlinger B, Stoeckle E, Meeus P, Coindre JM, Scoazec JY, Emile JF, Ranchere D, Le Cesne A. [Recommendations for the management of GIST patients]
    Bull Cancer. 2005 Oct 1;92(10):907-18. French.

    Ouzzif A, Seddik H, Boulez J, Scoazec JY, Lapalus MG.
    [Digestive protein loss from an ileal multifocal stromal tumor]
    Gastroenterol Clin Biol. 2005 Oct;29(10):1066-8. French.

    Blay JY, Le Cesne A, Alberti L, Ray-Coquart I.
    Targeted cancer therapies.
    Bull Cancer. 2005 Feb;92(2):E13-8. Review.

    Bouche O, Lagarde S.
    [Stomach cancer]
    Rev Prat. 2005 Jan 31;55(2):123-30. Review. French.

    Bonvalot S.
    [Surgical management of GIST in the era of Gleevec]
    Ann Chir. 2005 Mar;130(3):144-51. Epub 2004 Nov 18. Review. French.
    Retour en haut de la page

    2004

    Baty V, Blay JY, Michalet V, Prost B, Agard C, Ranchere-Vince D, Fontaumard E, Ray-Coquard I.
    [Asymptomatic stromal tumor of the colon revealed by classic Kaposi's sarcoma in an HIV negative patient]
    Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):925-7. French..

    Landi B, Lecomte T, Berger A, Cellier C.
    [Clinical management of gastrointestinal stromal tumors]
    Gastroenterol Clin Biol. 2004 Oct;28(10 Pt 1):893-901. Review. French.

    2003

    Ray-Coquard I, Le Cesne A, Michallet V, Boukovinas I, Ranchere D, Thiesse P, Baty V, Blay JY.
    [Gastro-intestinal stromal tumors: news and comments]
    Bull Cancer. 2003 Jan;90(1):69-76. Review. French.

    2002

    Clere F, Carola E, Halimi C, de Gramont A, Bonvalot S, Panis Y, Carnot F.
    [Current findings on gastrointestinal stromal tumors: seven observations of malignant tumors]
    Rev Med Interne. 2002 Jun;23(6):499-507. French.

    Bui BN, Tabrizi R, Dagada C, Trufflandier N, St ckle E, Coindre JM
    [Update on soft tissue sarcomas]
    Bull Cancer. 2002 Jan;89(1):100-7. Review. French.

    Taniere P, Poncet G, Atieh R, Saurin JC, Henry L, Scoazec JY. [All digestive tumors expressing c-kit protein are not stromal tumors]
    Gastroenterol Clin Biol. 2002 Nov;26(11):1057-8. French

    2001

    Balaton AJ, Coindre JM, Cvitkovic F.
    [Gastrointestinal stromal tumors]
    Gastroenterol Clin Biol. 2001 May;25(5):473-82. Review. French.

    Ray-Coquard I, Cesne AL, Blay JY
    [STI571 and gastro intestinal stromal tumors]
    Bull Cancer. 2001 Jul;88(7):661-2. Review. French.
    Retour en haut de la page





    Nous contacter : lien mail  ou Téléphone : (+33) 1 49 09 59 28.

    Ce site a été créé le 10 avril 2006 par Pr Jean-François Emile (texte et photographies), Patricia Martel et Thierry Olivier, Eric Vercherat (conception et réalisation).
    Site mis à jour par Eric Vercherat
    Dernière mise à jour : Avril 2010